ArticleCancer letters2007

Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model.

Xuefeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.